Please login to the form below

Not currently logged in
Email:
Password:

Havas Group acquires German comms agency Bird & Schulte

Freiburg-based firm will now operate as Havas Life Bird & Schulte

havas 

Havas Group has acquired Freiburg-based health and wellness agency Bird & Schulte Advertising.

The German agency covers a range of sectors including advertising, digital media, events and medical education and will now operate as Havas Life Bird & Schulte.

Donna Murphy, global CEO of Havas Health, said: “Our partnership will combine industry-leading strategy and insight with highly honoured creativity to deliver best-in-class results for our clients with a grater market reach.

“We believe that Bird & Schulte's broad health and wellness brand-building expertise, its deep talent pool and its future-forward business model will add great value for our clients.”

Co-founders of the agency Jeremy Bird and Dr Monika Schulte will continue as joint managing directors of Havas Life Bird & Schulte, which will now look to tap into additional health and wellness clients and markets with Havas Health's backing.

Commenting on the acquisition, Schulte commented: “We are excited to be joining the Havas family. Through shared strategy, planning and account resources provided by Havas Health, Havas Life Bird & Schulte will be able to fulfil the needs of a far more significant client base.

“It allows us to continue our sustained growth while ensuring that we offer the same service, support and quality that our existing clients have come to expect.”

Article by
Kirstie Pickering

23rd January 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics